Keyphrases
Pediatric Acute-onset Neuropsychiatric Syndrome
100%
Clinical Guidance
66%
Nordic Countries
66%
Free Sialic Acid
50%
Pandas
50%
Patient Support
50%
Pantothenate Kinase-associated Neurodegeneration
50%
Untargeted Metabolomics
50%
Kearns-Sayre Syndrome
50%
Brain Maturation
50%
Clinical Trials
50%
Rare Diseases
50%
Cerebrospinal Fluid
50%
Design Challenges
50%
Preterm Infants
50%
Double-blind RCT
50%
Docosahexaenoic Acid
50%
Design Strategy
50%
Sphingomyelin
50%
Arachidonic Acid
50%
Lessons Learned
50%
Tau Protein
33%
Sweden
29%
Child Psychiatrists
25%
5-methyltetrahydrofolate
25%
Acid Groups
18%
Infection Management
16%
Denmark
16%
Consensus Document
16%
Norway
16%
United Kingdom
16%
Clinical Manifestations
14%
Inborn Errors of Metabolism
14%
Movement Disorders
14%
Natural History
14%
Collaborative Research
12%
Clinical Concepts
12%
Great Britain
12%
Diagnostic Work-up
12%
Sudden Onset
12%
Pediatric Neurologist
12%
Denmark-Norway
12%
Patient Care
12%
Clinical Setting
12%
Psychiatric Symptoms
12%
Somatic Symptoms
12%
Tract-based Spatial Statistics
12%
Diffusion Tensor Imaging
12%
Postmenstrual Age
12%
Gestational Age
12%
Medicine and Dentistry
Pediatrics
100%
Patient Support Group
50%
Pantothenate Kinase-Associated Neurodegeneration
50%
Rare Disease
50%
Streptococcus Infection
50%
Clinical Trial
50%
Diagnosis
20%
Inborn Error of Metabolism
14%
Stereotypic Movement Disorder
14%
Symptom
10%
Patient Care
10%
Psychiatrist
10%
Somatics
10%
Degenerative Disease
7%
Bioassay
7%
Disease Exacerbation
7%
Lysosomal Storage Disease
7%
Storage Disease
7%
Treatment Response
7%
Disease
7%
Patient Selection
7%
Central Nervous System
7%
